These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7974813)

  • 21. Myopathy with tubulin-reactive inclusions in two cats.
    Shelton GD; Sturges BK; Lyons LA; Williams DC; Aleman M; Jiang Y; Mizisin AP
    Acta Neuropathol; 2007 Nov; 114(5):537-42. PubMed ID: 17393175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immobility reduces muscle fiber necrosis in dystrophin deficient muscular dystrophy.
    Kimura S; Ikezawa M; Nomura K; Ito K; Ozasa S; Ueno H; Yoshioka K; Yano S; Yamashita T; Matuskura M; Miike T
    Brain Dev; 2006 Aug; 28(7):473-6. PubMed ID: 16516424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dystrophin is localized to the plasma membrane of human skeletal muscle fibers by electron-microscopic cytochemical study.
    Carpenter S; Karpati G; Zubrzycka-Gaarn E; Bulman DE; Ray PN; Worton RG
    Muscle Nerve; 1990 May; 13(5):376-80. PubMed ID: 2189068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnostic methodology in muscular pathologies].
    Navarro-Fdez Balbuena C; Teijeira-Bautista S
    Rev Neurol; 2003 Oct 16-31; 37(8):766-9. PubMed ID: 14593637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy.
    Askanas V; Engel WK; Yang CC; Alvarez RB; Lee VM; Wisniewski T
    Am J Pathol; 1998 Apr; 152(4):889-95. PubMed ID: 9546349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma membrane cytoskeleton of muscle: a fine structural analysis.
    Watkins SC; Cullen MJ; Hoffman EP; Billington L
    Microsc Res Tech; 2000 Feb 1-15; 48(3-4):131-41. PubMed ID: 10679961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Congenital myopathies at their molecular dawning.
    Goebel HH
    Muscle Nerve; 2003 May; 27(5):527-48. PubMed ID: 12707973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of polyglucosan inclusions in skeletal muscle.
    Valentine BA; Cooper BJ
    Neuromuscul Disord; 2006 Oct; 16(9-10):603-7. PubMed ID: 16919952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidative stress and predominant Abeta42(43) deposition in myopathies with rimmed vacuoles.
    Tateyama M; Takeda A; Onodera Y; Matsuzaki M; Hasegawa T; Nunomura A; Hirai K; Perry G; Smith MA; Itoyama Y
    Acta Neuropathol; 2003 Jun; 105(6):581-5. PubMed ID: 12734664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Familial myopathy with desmin storage seen as a granulo-filamentar, electron-dense material without mutation of the alphabeta-crystallin gene].
    Pou Serradell A; Lloreta Trull J; Corominas Torres J; Guicheney P
    Neurologia; 2001 May; 16(5):195-203. PubMed ID: 11412718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of dystrophin and utrophin staining in childhood muscular dystrophy.
    Sundaram C; Vydehi B; Meena K; Murthy J
    Indian J Pathol Microbiol; 2004 Jul; 47(3):367-9. PubMed ID: 16295426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Light-microscopic study of the beta 1 integrin subunit in human skeletal muscle.
    Heub D; Neundörfer B
    Clin Neuropathol; 1997; 16(6):319-27. PubMed ID: 9401799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nucleolar characteristics of reducing bodies in reducing body myopathy.
    Shinde A; Nakano S; Kusaka H; Nakaya Y; Sawada H; Kohara N; Shibasaki H
    Acta Neuropathol; 2004 Mar; 107(3):265-71. PubMed ID: 14735304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrastructural myopathology in the molecular era.
    Goebel HH; Stenzel W
    Ultrastruct Pathol; 2013 Oct; 37(5):328-31. PubMed ID: 24047350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drosophila Dystrophin is required for integrity of the musculature.
    van der Plas MC; Pilgram GS; de Jong AW; Bansraj MR; Fradkin LG; Noordermeer JN
    Mech Dev; 2007 Aug; 124(7-8):617-30. PubMed ID: 17543506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Muscular magnetic resonance imaging for evaluation of myopathies in children].
    Peters SA; Köhler C; Schara U; Hohendahl J; Vorgerd M; Nicolas V; Heyer CM
    Klin Padiatr; 2008; 220(1):37-46. PubMed ID: 18098096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal accumulation of prion protein mRNA in muscle fibers of patients with sporadic inclusion-body myositis and hereditary inclusion-body myopathy.
    Sarkozi E; Askanas V; Engel WK
    Am J Pathol; 1994 Dec; 145(6):1280-4. PubMed ID: 7992832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New insights into the skeletal muscle phenotype of equine motor neuron disease: a quantitative approach.
    Palencia P; Quiroz-Rothe E; Rivero JL
    Acta Neuropathol; 2005 Mar; 109(3):272-84. PubMed ID: 15616793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fetus-like dystrophin expression and other cytoskeletal protein abnormalities in centronuclear myopathies.
    Mora M; Morandi L; Merlini L; Vita G; Baradello A; Barresi R; Di Blasi C; Blasevich F; Gebbia M; Daniel S
    Muscle Nerve; 1994 Oct; 17(10):1176-84. PubMed ID: 7935525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring autophagy in muscle diseases.
    Malicdan MC; Noguchi S; Nishino I
    Methods Enzymol; 2009; 453():379-96. PubMed ID: 19216917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.